The Sacklers transfer Purdue Pharma’s $10 billion to its other companies

17.12.2019 - Evdokimov Roman
The Sacklers transfer Purdue Pharma’s $10 billion to its other companies

The Sacklers transfer Purdue Pharma’s $10 billion to its other companies

The owners of Purdue Pharma, the Sackler family, transferred more than $10 billion in a decade from the OxyContin maker to its trust and holding companies, according to a New York Times report on Monday, citing the drugmaker’s newly-commissioned audit.

The audit is likely presumed to add further scrutiny on how much the Sackler family should pay to resolve lawsuits that Purdue Pharma faced regarding the U.S. opioid epidemic, the New York Times added.

From state and local government-filed lawsuits, it alleged that Purdue and the Sacklers contributed to a public health crisis, claiming the lives of nearly 400,000 people since 1999 by aggressively marketing opioids while downplaying its addiction and overdose risks.

The audit showed that from 2008 through 2017, Purdue’s payouts to the Sackler family totaled $10.7 billion. The auditors reported that they did not know how much cash distributed to the Sacklers was actually used to pay taxes.

“We need full transparency into their total assets and must know whether they sheltered them in an effort to protect against creditors and victims,” New York Attorney General Letitia James said. “We are committed to holding the Sacklers responsible for the role they played in fueling the opioid crisis and will not stop fighting until we have achieved justice for victims.”

Risk disclaimer "Market Solutions Ltd – Suite 305 Griffith Corporate Centre P.O. Box 1510 Beachmont, Kingstown, St Vincent and the Grenadines is a financial services institution outside the European Union Area, which is subject to the supervision of the IFMRRC Certificate 0395 AA V0128 Trading in Forex/ CFDs and Other Derivatives is highly speculative and carries a high level of risk. It is possible to lose all your capital. 70% of trading deals can be unprofitable. These products may not be suitable for everyone and you should ensure that you understand the risks involved. Seek independent advice if necessary. Speculate only with funds that you can afford to lose. This Website may contain information in particular regarding financial services and products that could be regarded b a E.U. supervisory authority as an offer of financial services targeted in Europe. ESMA intervention measures do not apply to customers of Market solutions Ltd and it is your responsibility to choose a company which is most suitable for your trading needs. By clicking continue you confirm that you have read, understood and agree to the risk disclosures, terms of service, cash policies, privacy policies and this notice and that you are visiting this website on your own initiative, without any encouragement whatsoever from umarkets.ai or Market Solutions limited." Cookies notification: We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we assume that you are happy with it. Read more. Continue
×

Help with deposit?